First Light Asset Management, LLC Maxcyte, Inc. Transaction History

First Light Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$3.69 - $5.35 $1.82 Million - $2.64 Million	493,344 Added 36.16%	1,857,566 $8.53 Million
Q1 2023 May 15, 2023	SELL	$4.03 - $5.89 $4,517 - $6,602	-1,121 Reduced 0.08%	1,364,222 $6.75 Million
Q4 2022 Feb 14, 2023	BUY	$4.92 - $7.4 $13,776 - $20,720	2,800 Added 0.21%	1,365,343 $7.45 Million
Q3 2022 Nov 14, 2022	BUY	$4.52 - $6.51 $194,604 - $280,281	43,054 Added 3.26%	1,362,543 $8.86 Million
Q2 2022 Aug 12, 2022	SELL	$3.59 - $6.81 $6,882 - $13,054	-1,917 Reduced 0.15%	1,319,489 $6.24 Million
Q1 2022 May 13, 2022	BUY	$5.26 - $10.84 $468,818 - $966,158	89,129 Added 7.23%	1,321,406 $9.24 Million
Q4 2021 Feb 14, 2022	BUY	$8.87 - $12.94 $2.11 Million - $3.07 Million	237,607 Added 23.89%	1,232,277 $12.6 Million
Q3 2021 Nov 12, 2021	BUY	$12.21 - $17.2 $12.1 Million - $17.1 Million	994,670 New	994,670 $12.1 Million

124

65.6M

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $451M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Light Asset Management, LLC with notifications on news.